| CardioMEMS, Inc. is a medical device company focused on the application of Microelectromechanical systems (MEMS) technology to create innovative devices for the diagnosis, treatment and management of chronic diseases. CardioMEMS is developing an implantable wireless sensor targeted for the Abdominal Aortic Aneurysm (AAA) and Congestive Heart Failure (CHF) markets. There are approximately 200,000 new cases of AAAs in the US diagnosed each year and it is the 3rd leading cause of death in men over 60. |
